is defined as inflammation conjunctive in the eye caused due to an allergic reaction to substances like pollen, household dust, animal dander and mold spores especially during hay season. This disease is characterised by some of the common symptoms such as red, itchy, watery, and burning eyes are common symptoms of allergic conjunctivitis or puffy eyes in the morning. Globally increasing awareness amongst people about the disease and developing medical infrastructure in emerging economies providing easy access to the treatment for Allergic conjunctivitis treatments.
This report identifies the Allergic conjunctivitis market
size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to Allergic conjunctivitis treatment market.
North America is the largest market owing to the high prevalence of allergic conjunctivitis in the region. North American allergic conjunctivitis treatment market is followed by Europe and Asia-Pacific as the second and third largest regional market respectively. Demand for the allergic conjunctivitis treatment is expected to grow the fastest in the Asia Pacific region due to increasing medical infrastructure in the region making easy access for the treatments and also rapid urbanization and increasing pollution has resulted into higher cases for allergic conjunctivitis in the several regional countries. This report segments global Allergic conjunctivitis treatment market on the basis of disease type, treatment type and regional market as follows:
- This report on global allergic Conjunctivitis market also covers major disease type of allergice conjunctivitis including: Seasonal Allergic Conjunctivitis, Perennial Allergic Conjunctivitis, Giant Papillary Conjunctivitis, Vernal Kerato Conjunctivitis, Atopic Kerato Conjunctivitis
- On the basis of current available treatments global allergic conjunctivitis market is segmented as follows: Antihistamines, Mast Cell Stabilizers, Olopatadine, Epinastine, Nonsteroidal Anti-Inflammatory Drugs and Others
- This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets for allergic conjunctivitis in each of the region.
Sample Companies Profiled in this Report are:
- Aciex Therapeutics
- Sun Pharma Advanced Research Company Ocular Therapeutix
- Sirion Therapeutics
- Boehringer Ingelheim